Site Members can sign up for company wide alerts
Investigation Overview
San Diego, Feb. 14, 2012 (Shareholders Foundation) -- An new investigation on behalf of investors in shares of Cell Therapeutics, Inc. (NASDAQ:CTIC) was announced over new potential securities laws violations by certain officers and directors at Cell Therapeutics in connection with its statements in regards to its New Drug Application for Pixuvri(TM). The new investigation by a law fi...
You must register (for free) or login to view the entire investigation.